Both Etoricoxib and Celecoxib are effective in the treatment of gout, but it is not possible to evaluate which drug is better, and the specific therapeutic effect varies from person to person. Etoricoxib tablets are indicated for conditions including acute and chronic osteoarthritis, acute gouty arthritis, and primary dysmenorrhea. Adverse reactions such as dyspepsia, nausea, epigastric pain, diarrhea, nasopharyngitis, upper respiratory tract infections, dizziness, headache, hypertension, and urinary tract infections may occur after using the drug. Celecoxib is indicated for use including the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis in adults, and the treatment of acute pain in adults. Adverse reactions such as abdominal pain, sinusitis, dyspepsia, upper respiratory tract infections, and rash may occur after administration. Both etoricoxib and celecoxib are anti-inflammatory, analgesic and antipyretic, and both can be used to treat gout, but the therapeutic effect varies from person to person. Note that both should be contraindicated in people who are allergic to the product, people with severe heart failure, people who have undergone coronary artery bypass graft surgery, people who have induced an allergic reaction after taking non-steroidal anti-inflammatory drugs, people who have active peptic ulcers, bleeding and so on. All of the above drugs should be under the guidance of a specialist, and should not be used without authorization to avoid adverse effects.